Prerna Mewawalla, Myeloma and Transplant Physician, Associate Professor at Drexel University College of Medicine, shared a post on LinkedIn:
“Looking forward to speaking at the National Immune Cell Effector Therapy (ICE-T) Conference this spring.
- Sheraton Charlotte Hotel – Charlotte, North Carolina
- April 18, 2026
- Register here.
I’ll be presenting on ‘Bispecific in Multiple Myeloma: Teclistamab, Elranatamab, and Beyond.’
Immune cell–redirecting therapies continue to redefine treatment paradigms in myeloma. With bispecifics now moving into earlier lines, we’re facing important real-world questions:
- Optimal sequencing with CAR-T
- Infection mitigation strategies
- Outpatient step-up dosing models
Excited to be connecting with colleagues in Charlotte and advancing the conversation on the future of immune cell effector therapy.”
Other articles featuring Prerna Mewawalla on OncoDaily.
